View in EDS HTML Full Text PDF Full Text

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.

Saved in:
Bibliographic Details
Title: Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.
Authors: Riek, Myriam1 (AUTHOR) myriam.riek@scqm.ch, Scherer, Almut1 (AUTHOR), Möller, Burkhard2 (AUTHOR), Ciurea, Adrian3 (AUTHOR), von Mühlenen, Ines4 (AUTHOR), Gabay, Cem5 (AUTHOR), Kyburz, Diego6 (AUTHOR), Brulhart, Laure7 (AUTHOR), von Kempis, Johannes8 (AUTHOR), Mueller, Ruediger B.9 (AUTHOR), Hasler, Paul10 (AUTHOR), Strahm, Tanja1 (AUTHOR), von Känel, Sabine1 (AUTHOR), Zufferey, Pascal11 (AUTHOR), Dudler, Jean12 (AUTHOR), Finckh, Axel5 (AUTHOR)
Source: Scientific Reports. 11/18/2023, Vol. 13 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-023-44841-w